Integrated Annual Report

Overview

The report presents Antibiotice SA's 2024 transition to ESRS/CSRD reporting, supported by a double materiality analysis. It reports a 64% reduction in market-based Scope 2 emissions from 2019, completion of a 2.5 MW photovoltaic plant, and more than 20% lower water consumption versus 2019. The workforce totaled 1,357 employees, while five critical medicines were launched in eight new international territories.

Document

Report type: Integrated Report
Scope: Full report
Fiscal year: 2024
Period: Ends 31 December 2024
Language: English
Pages
File size
Restatement: Disclosed

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP
Other

Commitments

UN Global Compact
UN Guiding Principles
Science Based Targets initiative

Materiality

Assessment
Basis

Assurance

Provider
Level
Scope
Statement included
Metrics assured

Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services